Advertisement

Transcutaneous Oxygen Pressure Measurements with an Electrode Core Temperature of 37 °C

  • A. Creutzig
  • D. Dau
  • K. Alexander
Conference paper

Abstract

The oxygen pressure of the healthy skin fluctuates between 0 and 4 mm Hg [5]. The application of hyperemizating ointment or heat causes skin oxygen pressure to rise; maximum hyperemia results at temperatures above 40 °C, while the blood flow remains constant [8]. A further increase in blood flow, such as one induced by drugs, cannot be expected, just as a reactive hyperemia cannot be measured. In earlier investigations, a uniform decline in tcPO2 was observed when an electrode was used at 44 °C in patients with arterial occlusive disease under an intra-arterial infusion of various drugs. This we interpreted as a steal phenomenon [2]. If, however, electrode core temperatures between 37 °C and 39 °C are selected, changes in the cutaneous blood flow can be detected [6]. In the following, the results of tcPO2 investigations using an electrode core temperature of 37 °C are reported.

Keywords

Oxygen Pressure Skin Blood Flow Reactive Hyperemia Arterial Occlusive Disease Cutaneous Blood Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bollinger, A., E.Lüthy: Kompensationsgrad arterieller Verschlüsse und Wirkung intravenös verabreichter vasoaktiver Medikamente. Schweiz, med. Wschr. 97 (1967) 1220–1225Google Scholar
  2. 2.
    Creutzig, A., K. Alexander: Die Bestimmung des transkutanen Sauerstoffdruckes der durchblutungsgestörten Extremität bei konservativer Therapie der AVK. Dt. Ges. Inn. Med. 89 (1983) 536–540Google Scholar
  3. 3.
    Creutzig, A., D. Dau, K. Alexander: Transkutaner Sauerstoffdruck während intraarterieller Infusionen. VASA 13 (1984) 207–212PubMedGoogle Scholar
  4. 4.
    Creutzig, A., M.Lux, K. Alexander: Muscle tissue oxygen pressure fields and transcutaneous oxygen pressure in healthy men during intra-arterial Prostaglandin E1 infusion. Intern. Angiol. 3 (1984)105–110Google Scholar
  5. 5.
    Evans, N.T.S., P. F. D. Naylor: The systemic oxygen supply to the surface of human skin. Resp. Physiol. 3 (1967) 21–37CrossRefGoogle Scholar
  6. 6.
    Ewald, U., G. Rooth, T.Tuvemo: Postischemic hyperaemia studied with a transcutaneous oxygen electrode used at 33–37 °C. Scand. J. Clin. Lab. Invest. 41 (1981) 641–645PubMedCrossRefGoogle Scholar
  7. 7.
    Gottstein, U., R. Felix, H.D.Flad, I.Sedlmayr: Untersuchungen zur Wirkung von Nikotinsäure und Adenosinmonophosphat auf Haut- und Muskeldurchblutung von Gefäßgesunden und Kranken mit peripheren Durchblutungsstörungen. Z. Kreisl. Forsch. 55 (1966) 970–987Google Scholar
  8. 8.
    Huch, R., A. Huch, D.W.Lübbers: Transcutaneous pO2. Thieme-Verlag, Stuttgart (1981)Google Scholar
  9. 9.
    Nielsen, P.E., S.L.Nielsen, P.Holstein, H.L.Poulsen, E.H.Hansen, N.A.Lassen: Intraarterial infusion of Prostaglandin E1 in normal subjects and patients with peripheral arterial disease. Scand. J. Clin. Lab. Invest. 36 (1976) 633–640PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • A. Creutzig
  • D. Dau
  • K. Alexander

There are no affiliations available

Personalised recommendations